Stabilization of the SARS-CoV-2 Receptor Binding Domain by Protein Core Redesign and Deep Mutational Scanning
Stabilizing antigenic proteins as vaccine immunogens or diagnostic reagents is a stringent case of protein engineering and design as the exterior surface must maintain recognition by receptor(s) and antigen-specific antibodies at multiple distinct epitopes. This is a challenge, as stability-enhancing mutations must be focused on the protein core, whereas successful computational stabilization algorithms typically select mutations at solvent-facing positions. In this study we report the stabilization of SARS-CoV-2 Wuhan Hu-1 Spike receptor binding domain (S RBD) using a combination of deep mutational scanning and computational design, including the FuncLib algorithm. Our most successful design encodes I358F, Y365W, T430I, and I513L RBD mutations, maintains recognition by the receptor ACE2 and a panel of different anti-RBD monoclonal antibodies, is between 1-2°C more thermally stable than the original RBD using a thermal shift assay, and is less proteolytically sensitive to chymotrypsin and thermolysin than the original RBD. Our approach could be applied to the computational stabilization of a wide range of proteins without requiring detailed knowledge of active sites or binding epitopes, particularly powerful for cases when there are multiple or unknown binding sites.
Errataetall: |
UpdateIn: Protein Eng Des Sel. 2022 Feb 17;35:. - PMID 35325236 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - year:2021 |
---|---|
Enthalten in: |
bioRxiv : the preprint server for biology - (2021) vom: 24. Nov. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Leonard, Alison C [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 29.03.2022 published: Electronic UpdateIn: Protein Eng Des Sel. 2022 Feb 17;35:. - PMID 35325236 Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1101/2021.11.22.469552 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM33382489X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM33382489X | ||
003 | DE-627 | ||
005 | 20231225222436.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1101/2021.11.22.469552 |2 doi | |
028 | 5 | 2 | |a pubmed24n1112.xml |
035 | |a (DE-627)NLM33382489X | ||
035 | |a (NLM)34845448 | ||
035 | |a (PII)2021.11.22.469552 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Leonard, Alison C |e verfasserin |4 aut | |
245 | 1 | 0 | |a Stabilization of the SARS-CoV-2 Receptor Binding Domain by Protein Core Redesign and Deep Mutational Scanning |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 29.03.2022 | ||
500 | |a published: Electronic | ||
500 | |a UpdateIn: Protein Eng Des Sel. 2022 Feb 17;35:. - PMID 35325236 | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Stabilizing antigenic proteins as vaccine immunogens or diagnostic reagents is a stringent case of protein engineering and design as the exterior surface must maintain recognition by receptor(s) and antigen-specific antibodies at multiple distinct epitopes. This is a challenge, as stability-enhancing mutations must be focused on the protein core, whereas successful computational stabilization algorithms typically select mutations at solvent-facing positions. In this study we report the stabilization of SARS-CoV-2 Wuhan Hu-1 Spike receptor binding domain (S RBD) using a combination of deep mutational scanning and computational design, including the FuncLib algorithm. Our most successful design encodes I358F, Y365W, T430I, and I513L RBD mutations, maintains recognition by the receptor ACE2 and a panel of different anti-RBD monoclonal antibodies, is between 1-2°C more thermally stable than the original RBD using a thermal shift assay, and is less proteolytically sensitive to chymotrypsin and thermolysin than the original RBD. Our approach could be applied to the computational stabilization of a wide range of proteins without requiring detailed knowledge of active sites or binding epitopes, particularly powerful for cases when there are multiple or unknown binding sites | ||
650 | 4 | |a Preprint | |
700 | 1 | |a Weinstein, Jonathan J |e verfasserin |4 aut | |
700 | 1 | |a Steiner, Paul J |e verfasserin |4 aut | |
700 | 1 | |a Erbse, Annette H |e verfasserin |4 aut | |
700 | 1 | |a Fleishman, Sarel J |e verfasserin |4 aut | |
700 | 1 | |a Whitehead, Timothy A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t bioRxiv : the preprint server for biology |d 2020 |g (2021) vom: 24. Nov. |w (DE-627)NLM31090014X |7 nnns |
773 | 1 | 8 | |g year:2021 |g day:24 |g month:11 |
856 | 4 | 0 | |u http://dx.doi.org/10.1101/2021.11.22.469552 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2021 |b 24 |c 11 |